INTRODUCTION
Hydrotropes, co-solvents and water soluble solutes have been observed to enhance the aqueous solubility of poorly water soluble drugs. It has been demonstrated that synergistic effect can be obtained by mixed solvency concept. The use of hydrotropy can be utilized in titrimetric and spectrophometric estimation of a large number of poorly water soluble drug substances. The mixed solvency approach discourages the use of organic solvents in large concentration (which may prove toxic) for development of a dosage forms. A number of solubilizers may be taken in small concentration curtailing their toxic levels and shows significant improvement in the solubility of the of poorly water soluble drugs [1] [2] [3] [4] [5] [6] [7] [8] [9] .
MATERIALS UNDER METHODS
Gift sample of drug Diclofenac sodium was procured from M/s Aerrow pharmaceuticals, Indore, M.P. All the chemicals and solvents used were of analytical grade. Distilled water was used to prepare the solutions of solubilizers. A spectrophotometer (UV-1700 Shimadzo) was used for quantitative analysis.
METHODS
Preparation of calibration curve of Diclofenac sodium: 40 mg of Diclofenac sodium was accurately weighed and transferred to 50 ml volumetric flask. To this 40 ml of distilled water was added. The flask was shaken to solubilize the drug and volume was made upto the mark with distilled water. The stock solution was further diluted with distilled water to obtain various dilutions containing between 15-90 µg/ml. Absorbance was noted at 276nm against reagent blanks to get the calibration curve. The Solubilityof diclofenec sodium in distilled water was observed and shown in Table (1) .
ANALYSIS OF DICLOFENAC SODIUM (API) BY PROPOSED METHOD:
A blend (30%w/v constant) of solubilizers was prepared by using varying concentrations of the solvents as shown below for Blends (1-4) ABSTRACT 'Mixed-solvency ' concept is the phenomenon to increase the solubility of poorly water-soluble drugs in the aqueous solution containing blends of hydrotropic agents, co-solvents and water soluble solutes which may give synergistic enhancement effect on solubility of such drugs. In the present study mixed -solvency concept has been applied for the enhancement of aqueous solubility of a poorly water-soluble drug diclofenec sodium(selected as a model drug) by making blends of randomly selected water-soluble substances from among the hydrotropes (urea, sodium citrate) ; water soluble solutes(PEG4000, PEG6000); and co-solvents(PEG300,PEG400). The aqueous solubility of diclofenac sodium was observed at room temperature in the randomly selected blends of different combinations keeping total concentration 30%w/v constant. Quantitative analysis of bulk drug diclofenec sodium was done by u.v. spectrophotometric estimation at λmax at 276 nm in concentration range of 15-90 µg/ml . The results suggests significant enhancement in the solubility of the poorly water soluble drug sample containing different combinations of such substances (blends). Key words: poorly water-soluble drugs, solubility, mixed solvency.
Bulk drug was first dissolved in 10ml of blend 1.The solution was vigorously shaken for a definite time with regular intervals until a supersaturated solution is obtained. The resulting solution was diluted upto 1000ml with the blend. Absorbance of this solution was noted at 276nm against the solvent blend. The same procedure was followed with the other blends (2-4) and absorbance was noted at the same wavelength. The corresponding concentration gives the solubility of the drug and thus the enhanced solubility of the drug was calculated by comparing the solubility of the drug in water.
RESULTS AND DISCUSSION
The results obtained are shown in Table (1) for Solubility of diclofenec sodium in water as well as in Table ( 2) Solubility of diclofenec sodium in different blends (1) (2) (3) (4) . It is evident that there was improvement in the solubility of diclofenac sodium in (30% blend) containing different combinations of urea, PEG4000, PEG6000, PEG300, PEG400 and sodium acetate. On comparing Table-1 and  Table- 2, the drug solubility was found to be enhanced by 1.83, 2.57, 3.08 and 3.2 folds with blend-1, 2, 3 and 4 respectively. The greatest enhancement in solubility was observed in case of Blend 4 and least in case of Blend 1. 
CONCLUSION
The solubility of the Diclofenac Sodium containing different combinations of urea, PEG4000, PEG6000, PEG300, PEG400 and sodium acetate was enhanced significantly, using this mixed-solvency approach. Therefore the results suggest that mixed -solvency approach for the enhancement of solubility of poorly watersoluble sample drug can also be used successfully for other poorly-water soluble drugs.
